Search
Now showing items 1-10 of 11
Out of range laboratory values: a major reason for exclusion from a phase 1 HIV vaccine clinical trial
(University of Nairobi, 2006)
Safety and immunogenicity of DNA and MVA HIVA vaccines in Phase-1 vaccine trials in Nairobi, Kenya
(University of Nairobi, 2004)
Reasons for declining enrolment among eligible volunteers in a phase II HIV vaccine trial in Kenya
(University of Nairobi, 2004)
Volunteer Recruitment for phase 1 HIV Vaccine Trials in Nairobi
(University of Nairobi, 2002)
Safety Issues, DNA & MVA HIV Vaccine Trials at KAVI Oral presentation
(University of Nairobi, 2003-01)
Safety profile of DNA and MVA HIV preventive vaccines
(University of Nairobi, 2004)
Pre-screening And ‘banking’ Participants For Clinical Research – Experience From Kenya Aids Vaccine Initiative (kavi)
(University of Nairobi, 2013-06)
Introduction: Participation in clinical research is a voluntary exercise whereby
a participant makes an informed choice to join a study. Clinical trials are
robust experiments that require efficiency. HIV vaccine clinical ...
HIV vaccine clinical trials enrollment and retention: Experience from Kenya AIDS Vaccine Initiative
(University of Nairobi, 2005)